[HTML][HTML] Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures

JVA Franco, P Tesolin, JH Jung - Prostate international, 2023 - Elsevier
Lower urinary tract symptoms due to benign prostatic hyperplasia constitute a substantial
burden, affecting the quality of life of those affected by this condition. While watchful waiting …

The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global …

AF Awedew, H Han, B Abbasi… - The Lancet Healthy …, 2022 - thelancet.com
Background Benign prostatic hyperplasia is a common urological disease affecting older
men worldwide, but comprehensive data about the global, regional, and national burden of …

Comparison of contemporary surgical outcomes between holmium laser enucleation of the prostate and robotic-assisted simple prostatectomy

TM Shelton, C Drake, R Vasquez, M Rivera - Current Urology Reports, 2023 - Springer
Abstract Purpose of Review This study reviews contemporary literature on RASP and
HoLEP to evaluate perioperative outcomes, common complications, cost analytics, and …

Evaluation of an artificial intelligence chatbot for delivery of IR patient education material: a comparison with societal website content

CJ McCarthy, S Berkowitz, V Ramalingam… - Journal of Vascular and …, 2023 - Elsevier
Purpose To assess the accuracy, completeness, and readability of patient educational
material produced by a machine learning model and compare the output to that provided by …

[PDF][PDF] Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH

PJ Gilling, N Barber, M Bidair, P Anderson, M Sutton… - Can J Urol, 2022 - canjurol.com
Materials and methods: In a double-blinded, multicenter prospective randomized controlled
trial, 181 patients with moderate to severe LUTS secondary to BPH underwent TURP or …

Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia (2021 Edition)

XT Zeng, YH Jin, TZ Liu, FM Chen, DG Ding… - Military Medical …, 2022 - Springer
Benign prostatic hyperplasia (BPH) is highly prevalent among older men, impacting on their
quality of life, sexual function, and genitourinary health, and has become an important global …

Prostate tissue ablation and drug delivery by an image-guided injectable ionic liquid in ex vivo and in vivo models

YM Demirlenk, H Albadawi, Z Zhang, D Atar… - Science translational …, 2024 - science.org
Benign prostatic hyperplasia and prostate cancer are often associated with lower urinary
tract symptoms, which can severely affect patient quality of life. To address this challenge …

A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia

B Chughtai, S Rojanasarot, K Neeser, D Gultyaev… - PLoS …, 2022 - journals.plos.org
Treatment options for men with moderate-to-severe lower urinary tract symptoms (LUTS)
due to benign prostatic hyperplasia (BPH) have variable efficacy, safety, and retreatment …

Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study

Y Sahakyan, A Erman, N Bhojani, B Chughtai… - Prostate Cancer and …, 2023 - nature.com
Background Recently, minimally invasive therapies (MITs), such as water vapor thermal
therapy (WVTT) and prostatic urethral lift (PUL) have become an alternative to surgery or …

Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation

DD Nguyen, T Li, R Ferreira, M Baker Berjaoui… - Prostate Cancer and …, 2024 - nature.com
Introduction Benign prostatic hyperplasia (BPH) is one of the most common diseases
affecting men and can present with bothersome lower urinary tract symptoms (LUTS) …